Cargando…
Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis
Purpose: Pulmonary arterial hypertension (PAH) is a formidable disease with no effective treatment at present. With the goal of developing potential therapies, we attempted to determine whether ethyl pyruvate (EP) could alleviate PAH and its mechanism. Methods: Pulmonary smooth muscle cells were cul...
Autores principales: | Liu, Chuanzhen, Sun, Hourong, Tang, Mengmeng, Li, Jianhua, Zhang, Xiquan, Cao, Guangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684839/ https://www.ncbi.nlm.nih.gov/pubmed/34011805 http://dx.doi.org/10.5761/atcs.oa.21-00027 |
Ejemplares similares
-
Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model
por: Liu, Kai, et al.
Publicado: (2016) -
Ethyl Pyruvate Prevents Renal Damage Induced by Methylglyoxal-Derived Advanced Glycation End Products
por: Jung, Eunsoo, et al.
Publicado: (2019) -
The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells
por: Ramakrishnan, Latha, et al.
Publicado: (2018) -
Relationship between advanced glycation end-product accumulation in the skin
and pulmonary function
por: Kubo, Akira, et al.
Publicado: (2018) -
Ethyl pyruvate can alleviate alcoholic liver disease through inhibiting Nrf2 signaling pathway
por: Shen, Fei, et al.
Publicado: (2018)